Need professional-grade analysis? Visit stockanalysis.com
$174.07M
18.01
141
N/A
Sanara Medtech Inc (SMTI) trades on United States in USD. The company is classified in the Healthcare sector under the Medical Instruments & Supplies industry. The stock currently trades at $20.77, up 5.01% from the previous close.
Over the past year, SMTI has traded between a low of $16.34 and a high of $35.75. The stock has lost 31.0% over this period. It is currently 41.9% below its 52-week high.
Sanara Medtech Inc has a market capitalization of $174.07M, with a price-to-earnings ratio of 18.01.
Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns. It also develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; and TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement. The company has a license agreement with Rochal to develop, market, and sell antimicrobial products that include BIASURGE Advanced Surgical Solution, BIAKOS Antimicrobial Wound Gel, and BIAKOS Antimicrobial Skin and Wound Cleanser for the prevention and treatment of microbes on the human body. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.
Side-by-side comparison against top Healthcare peers.